- Home
- FGEN vs RMTI Comparison
FGEN vs RMTI Comparison
Compare FGEN & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- RMTI
- Stock Information
- Founded
- FGEN 1993
- RMTI 1994
- Country
- FGEN United States
- RMTI United States
- Employees
- FGEN N/A
- RMTI N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- FGEN Health Care
- RMTI Health Care
- Exchange
- FGEN Nasdaq
- RMTI Nasdaq
- Market Cap
- FGEN 33.5M
- RMTI 32.5M
- IPO Year
- FGEN 2014
- RMTI 1998
- Fundamental
- Price
- FGEN $7.01
- RMTI $0.98
- Analyst Decision
- FGEN Strong Buy
- RMTI Strong Buy
- Analyst Count
- FGEN 1
- RMTI 2
- Target Price
- FGEN $250.00
- RMTI $4.00
- AVG Volume (30 Days)
- FGEN 43.0K
- RMTI 449.6K
- Earning Date
- FGEN 08-12-2025
- RMTI 08-14-2025
- Dividend Yield
- FGEN N/A
- RMTI N/A
- EPS Growth
- FGEN N/A
- RMTI N/A
- EPS
- FGEN N/A
- RMTI N/A
- Revenue
- FGEN $6,996,000.00
- RMTI $97,727,000.00
- Revenue This Year
- FGEN N/A
- RMTI N/A
- Revenue Next Year
- FGEN N/A
- RMTI $11.16
- P/E Ratio
- FGEN N/A
- RMTI N/A
- Revenue Growth
- FGEN N/A
- RMTI 12.82
- 52 Week Low
- FGEN $4.50
- RMTI $0.78
- 52 Week High
- FGEN $29.00
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- FGEN 52.22
- RMTI 48.28
- Support Level
- FGEN $7.04
- RMTI $1.08
- Resistance Level
- FGEN $7.56
- RMTI $1.18
- Average True Range (ATR)
- FGEN 0.57
- RMTI 0.09
- MACD
- FGEN 0.03
- RMTI -0.01
- Stochastic Oscillator
- FGEN 45.20
- RMTI 4.76
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.